Gastric Neoplasm: Clinical Trials

8 trials for Gastric Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 8 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 5, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 22Not yet recruiting 1, Recruiting 1

Follow Gastric Neoplasm: new trials by email Literature Review of Gastric Neoplasm trials Research Report on Gastric Neoplasm

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression
Fruquintinib Combined with Sintilimab and Stereotactic Body Radiation Therapy - Gastric Neoplasm
Phase 2 / Phase 3Not yet recruitingQueling Liu302025-06-012025-05-16
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Docetaxel, Oxaliplatin, Leucovorin - Gastric Cancer, Stomach Cancer
Phase 2 / Phase 3RecruitingUkrainian Society of Clinical Oncology1502025-03-252025-05-06
RCT of Gastric ESD With or Without Epineprhine Added Solution
Endoscopic submucosal dissection, Epinephrine - Gastric Neoplasm, Early Gastric Cancer
Phase 3CompletedChinese University of Hong Kong8002020-01-102025-05-04
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
Gastrectomy with more than D2 dissection, Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy - Gastric Neoplasm
Phase 3CompletedHaruhiko Fukuda3162005-11-012016-09-22
GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
Surgery: Splenectomy, Surgery: Spleen-preservation - Gastric Neoplasm
Phase 3CompletedHaruhiko Fukuda5002002-06-012016-09-22
Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)
Surgery: abdominal and transhiatal approach, Surgery: left thoraco-abdominal approach - Gastric Neoplasm
Phase 3TerminatedJapan Clinical Oncology Group1671995-07-012009-02-03
A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer
Surgery: D2 dissection, Surgery: D2+paraaortic dissection - Gastric Neoplasm
Phase 3CompletedJapan Clinical Oncology Group5201995-07-012016-09-22
Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)
Gastrectomy with D2 or greater lymph node dissection, Gastrectomy+ chemotherapy - Gastric Neoplasm
Phase 3CompletedJapan Clinical Oncology Group2801993-01-012016-09-22

Narrower conditions

Stomach Neoplasms (8)  ·  Gastrointestinal Neoplasms (1)  ·  Neoplasms (1)

Broader conditions

Digestive System Diseases (8)  ·  Digestive System Neoplasms (8)  ·  Gastrointestinal Diseases (8)  ·  Neoplasms by Site (8)  ·  Stomach Diseases (8)  ·  Gastrointestinal Neoplasms (7)  ·  Neoplasms (7)

Interventions

Gastrectomy (2)  ·  Docetaxel (1)  ·  Endoscopic Mucosal Resection (1)  ·  Epinephrine (1)  ·  Fluorouracil (1)  ·  Leucovorin (1)  ·  Oxaliplatin (1)  ·  Radiosurgery (1)  ·  sintilimab (1)

Sponsors

Japan Clinical Oncology Group (3)  ·  Haruhiko Fukuda (2)  ·  Chinese University of Hong Kong (1)  ·  Queling Liu (1)  ·  Ukrainian Society of Clinical Oncology (1)

Countries

Japan (6)  ·  Hong Kong (1)  ·  Lithuania (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Ukraine (1)

Top investigators

Mitsuru Sasako, MD (2)  ·  Mitsuru Sasako, MD, PhD (2)  ·  Hiroshi Furukawa, MD, PhD (1)  ·  Hon Chi Yip, MBChB, FRCSEd (1)  ·  Mykyta Pepenin, MD (1)

Results publications

PMID 21104822, PMID 16887481, PMID 18669424, PMID 21336855, PMID 25605628, PMID 41620139